GB0526000D0 - Cytokine receptor - Google Patents

Cytokine receptor

Info

Publication number
GB0526000D0
GB0526000D0 GBGB0526000.5A GB0526000A GB0526000D0 GB 0526000 D0 GB0526000 D0 GB 0526000D0 GB 0526000 A GB0526000 A GB 0526000A GB 0526000 D0 GB0526000 D0 GB 0526000D0
Authority
GB
United Kingdom
Prior art keywords
cytokine receptor
cytokine
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0526000.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Priority to GBGB0526000.5A priority Critical patent/GB0526000D0/en
Publication of GB0526000D0 publication Critical patent/GB0526000D0/en
Priority to PCT/GB2006/004845 priority patent/WO2007072011A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5425IL-9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • A61K2039/55527Interleukins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0526000.5A 2005-12-21 2005-12-21 Cytokine receptor Ceased GB0526000D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0526000.5A GB0526000D0 (en) 2005-12-21 2005-12-21 Cytokine receptor
PCT/GB2006/004845 WO2007072011A1 (en) 2005-12-21 2006-12-21 Interleukin- 9 like receptor protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0526000.5A GB0526000D0 (en) 2005-12-21 2005-12-21 Cytokine receptor

Publications (1)

Publication Number Publication Date
GB0526000D0 true GB0526000D0 (en) 2006-02-01

Family

ID=35840866

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0526000.5A Ceased GB0526000D0 (en) 2005-12-21 2005-12-21 Cytokine receptor

Country Status (2)

Country Link
GB (1) GB0526000D0 (en)
WO (1) WO2007072011A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830454A (en) * 1996-08-30 1998-11-03 Ludwig Institute For Cancer Research Method for treating cell mediated autoimmune disorders using interleukin-9
WO1998024904A2 (en) * 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
GB0216661D0 (en) * 2002-07-17 2002-08-28 Ares Trading Sa Protein

Also Published As

Publication number Publication date
WO2007072011A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
GB0509275D0 (en) Synthetic receptor
ZA200803811B (en) Neuropolin antagonists
PL1963369T3 (en) Il-21 antagonists
IL187424A0 (en) C5a RECEPTOR ANTAGONISTS
IL190686A0 (en) Il-21 receptor antagonists
ZA200705237B (en) C5A receptor antagonists
GB0509276D0 (en) Synthetic receptor
GB0508010D0 (en) Intra-vaginal device
GB2426549B (en) Anchorages
PL1688672T3 (en) Supporting construction
HU3357U (en) Cushion
SI1686102T1 (en) Screed
AU305400S (en) Support
GB0414798D0 (en) Receptor
GB0525029D0 (en) Receptor Antagonist
GB2432516B (en) Footstool
GB0415860D0 (en) Solid supports
GB0613762D0 (en) Slabline structure
GB0516946D0 (en) Receptor
GB0526000D0 (en) Cytokine receptor
GB0413872D0 (en) Receptor
GB0405642D0 (en) Cytokine receptor
GB0522484D0 (en) Receptor
GB0522394D0 (en) Receptor
GB0522077D0 (en) Receptor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)